Senores Pharmaceuticals Limited has submitted a regulatory filing to both BSE Limited and National Stock Exchange of India Limited regarding scheduled meetings with analysts and institutional investors. The disclosure is made pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.
The company officials will attend an investor conference hosted by Antique Stock Broking on August 25, 2026, starting at 11:00 AM IST onwards. The meetings will include both group meetings and one-on-one (1x1) sessions, conducted in physical mode at Mumbai.
The company explicitly states that all discussions during these interactions will be based solely on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during these meetings.
The filing notes that changes to the schedule may occur due to exigencies on the part of either the host (Antique Stock Broking) or the company itself.
The document is digitally signed by Deval Rajnikant Shah, Whole-Time Director & CFO of Senores Pharmaceuticals Limited (DIN: 00332722), on August 20, 2026, at 18:24:40 IST.
Financial Impact
No financial impact is mentioned in the disclosure. This is a routine regulatory intimation of investor meeting schedules.